The drug companies got rich during the pandemic through massive government subsidies. Now, they want to raise the price of lifesaving treatment. Fostering competition could keep costs down.
Will It Be a Blue Wave?
With limited data, exactly how many Republican incumbents are in trouble is hard to know. But Democrats have good reason to think big.
Keep reading
Something went wrong. Please refresh the page and/or try again.
